What is the new weight-loss pill developed by Swedish scientists?

Swedish scientists have developed a new oral medication that boosts metabolism and controls blood sugar, distinct from appetite-suppressing GLP-1 drugs.

How does the new oral drug compare to Ozempic?

The new oral drug boosts metabolism instead of suppressing appetite and has shown fewer side effects than GLP-1s like Ozempic, potentially preserving muscle mass.

When will the new drug be available for patients with obesity?

The company developing the drug plans to conduct a larger phase 2 clinical trial with people with obesity, indicating future availability after further testing.

Home / Health / New Pill Boosts Fat Burning Without Muscle Loss

New Pill Boosts Fat Burning Without Muscle Loss

10 Dec

•

Summary

Novel oral medication enhances metabolism and controls blood sugar.
Study shows fewer side effects compared to popular GLP-1 drugs.
Drug may help preserve muscle mass, crucial for health and longevity.

New Pill Boosts Fat Burning Without Muscle Loss

A groundbreaking oral medication is emerging from research in Sweden, designed to boost the body's fat-burning capabilities and improve blood sugar control through a novel mechanism. Unlike popular GLP-1 drugs that primarily suppress appetite, this new treatment focuses on enhancing muscle metabolism. Initial studies involving both animals and human participants have shown promising results, including effective glucose management, increased fat burning, and importantly, the retention of muscle mass.

This experimental drug has demonstrated a favorable safety profile with fewer side effects compared to current injectables like semaglutides, which can cause appetite loss and gastrointestinal distress. The medication utilizes a new form of beta-2 agonist that benefits muscle function without overstimulating the heart. Researchers suggest it could be used independently or in conjunction with existing therapies, offering a new pathway for metabolic health improvement.